Clinical trials recruiting for Rectal Cancer Stage II
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Tislelizumab combined with chemotherapy | 1 |
| mFOLFOX regimen combined with Citrus Flavone Tablets (Alvenor) neoadjuvant treatment group | 1 |
| mFOLFOX regimen neoadjuvant therapy group | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alaska | 1 |
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
- The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
- The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
- ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
Related conditions
Trials recruiting for Rectal Cancer Stage II often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Rectal Cancer Stage II trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.